REONPARK · ES-BIAL-PD-001
The REONPARK study is a national registry in Spain documenting the use of COMT inhibitors in patients diagnosed with Parkinson's disease. The goal is to analyze their role in the clinical management of those patients who experience early motor fluctuations during the course of their disease.
REONPARK study. Spanish registry of the use of COMT inhibitors in the management of patients with Parkinson's disease experiencing early motor fluctuations.
Sponsor: BIAL
Phase: IV
Status: Follow-up